FOLH1 and posterior cortical atrophy: Sufficient PSMA induction might improve therapy effects of 177Lu-PSMA-617 in patients with PSMA-positive mCRPC [5], and furthermore, it may enhance detection rates of primary hormone-sensitive PCa.